Vancouver, British Columbia (Newsfile Corp. - July 14, 2022) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF) ("NervGen" the "Company"), a clinical stage biotech company dedicated to developing a first-in-class
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESVancouver, British Columbia (Newsfile Corp. - November 29, 2021) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF)
NervGen Pharma Corp Closes Non-Brokered Private Placement finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
NervGen Pharma Corp. Announces Overnight Marketed Equity Offering
NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF) (
NervGen the
Company ), a biotech company dedicated to creating innovative solutions for the treatment of nerve damage and neurodegenerative diseases, announced that it has launched an overnight, best efforts marketed public offering (the
Offering ) of units (the
Units ), each Unit being comprised of one common share of the Company and one-half of one common share purchase warrant (each whole warrant, a
Warrant ). The number of Units to be distributed under the Offering, the price of each Unit and the exercise price of each Warrant will be determined in the context of the market.